Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Clinical Journal of the American Society of Nephrology : CJASN|April 28, 2021
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome: Results from the BETonMACE Randomized Controlled TrialKamyar Kalantar-Zadeh, Gregory G Schwartz, Stephen J Nicholls, et al.Journal of Hepatology|August 28, 2017
Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970sPatricia Garvey, Niamh Murphy, Paula Flanagan, et al.Biomedicines|April 30, 2021
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In VitroDean Gilham, Audrey L Smith, Li Fu, et al.European Journal of Human Genetics : EJHG|August 26, 2010
Preparation and validation of the first WHO international genetic reference panel for Fragile X syndromeMalcolm Hawkins, Jennifer Boyle, Kathleen E Wright, et al.American Journal of Preventive Cardiology|August 30, 2022
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver diseasePeter P Toth, Gregory G Schwartz, Stephen J Nicholls, et al.Atherosclerosis|December 1, 2022
Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cellsSylwia Wasiak, Laura M Tsujikawa, Emily Daze, et al.Atherosclerosis|October 1, 2019
Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular diseaseMathias Haarhaus, Kausik K Ray, Stephen J Nicholls, et al.Clinical Epigenetics|November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetesSylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.Translational Neuroscience|January 15, 2024
The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammationSylwia Wasiak, Li Fu, Emily Daze, et al.Nutrients|June 26, 2026
Prune Consumption and Bone Health in Older Men: A One-Year Randomized Controlled TrialLauren T Ormsbee, Neda S Akhavan, Joseph Munoz, et al.Pageof 13